GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $37,000 | +32.1% | 172 | -28.6% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | +21.7% | 241 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $23,000 | +9.5% | 241 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $21,000 | -58.0% | 241 | -49.9% | 0.00% | -40.0% |
| Q4 2019 | $50,000 | -23.1% | 481 | -14.7% | 0.01% | -28.6% |
| Q3 2019 | $65,000 | -33.7% | 564 | -0.5% | 0.01% | -30.0% |
| Q2 2019 | $98,000 | +276.9% | 567 | +270.6% | 0.01% | +42.9% |
| Q1 2019 | $26,000 | -58.1% | 153 | -75.8% | 0.01% | -46.2% |
| Q4 2018 | $62,000 | +121.4% | 632 | +295.0% | 0.01% | 0.0% |
| Q3 2018 | $28,000 | -72.3% | 160 | -82.3% | 0.01% | -53.6% |
| Q3 2017 | $101,000 | -99.9% | 905 | -1.6% | 0.03% | +27.3% |
| Q2 2017 | $92,000,000 | -4.2% | 920 | +14.3% | 0.02% | -18.5% |
| Q1 2017 | $96,000,000 | +45.5% | 805 | +35.3% | 0.03% | +125.0% |
| Q4 2016 | $66,000,000 | +109900.0% | 595 | +32.2% | 0.01% | +9.1% |
| Q3 2016 | $60,000 | +57.9% | 450 | +5.9% | 0.01% | -8.3% |
| Q2 2016 | $38,000 | +35.7% | 425 | +6.2% | 0.01% | +20.0% |
| Q1 2016 | $28,000 | +180.0% | 400 | +166.7% | 0.01% | +150.0% |
| Q4 2015 | $10,000 | -33.3% | 150 | -14.3% | 0.00% | -20.0% |
| Q3 2015 | $15,000 | +25.0% | 175 | +75.0% | 0.01% | +25.0% |
| Q2 2015 | $12,000 | +33.3% | 100 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $9,000 | -10.0% | 100 | -33.3% | 0.00% | 0.0% |
| Q4 2014 | $10,000 | -64.3% | 150 | -56.9% | 0.00% | -50.0% |
| Q3 2014 | $28,000 | – | 348 | – | 0.01% | – |
| Q2 2014 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|